Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nfic
|
ENSMUSG00000055053.11 | nuclear factor I/C |
Nfib
|
ENSMUSG00000008575.11 | nuclear factor I/B |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr4_82483912_82484281 | Nfib | 15220 | 0.194629 | 0.73 | 3.4e-11 | Click! |
chr4_82483202_82483883 | Nfib | 15774 | 0.193594 | 0.67 | 5.4e-09 | Click! |
chr4_82502671_82503506 | Nfib | 2220 | 0.314135 | 0.53 | 1.4e-05 | Click! |
chr4_82502069_82502416 | Nfib | 2926 | 0.270194 | 0.52 | 1.8e-05 | Click! |
chr4_82503776_82503980 | Nfib | 1430 | 0.427814 | 0.48 | 9.9e-05 | Click! |
chr10_81426043_81427197 | Nfic | 494 | 0.538277 | 0.65 | 2.3e-08 | Click! |
chr10_81424113_81425703 | Nfic | 2206 | 0.110477 | 0.59 | 6.8e-07 | Click! |
chr10_81425716_81425867 | Nfic | 1323 | 0.186907 | 0.56 | 4.2e-06 | Click! |
chr10_81427267_81427429 | Nfic | 161 | 0.860036 | 0.53 | 1.2e-05 | Click! |
chr10_81450943_81451418 | Nfic | 4455 | 0.078067 | -0.42 | 7.6e-04 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_59438036_59438472 | 20.37 |
Gm13549 |
predicted gene 13549 |
38473 |
0.13 |
chr7_101394207_101396000 | 20.17 |
Arap1 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 |
448 |
0.73 |
chr19_36734732_36735279 | 18.44 |
Ppp1r3c |
protein phosphatase 1, regulatory subunit 3C |
1648 |
0.41 |
chr10_121836526_121837955 | 18.08 |
Gm48804 |
predicted gene, 48804 |
5182 |
0.22 |
chr9_50751156_50752468 | 17.97 |
Cryab |
crystallin, alpha B |
65 |
0.86 |
chr15_85653123_85654040 | 17.72 |
Lncppara |
long noncoding RNA near Ppara |
35 |
0.97 |
chr7_17059938_17060640 | 17.18 |
4833404L02Rik |
RIKEN cDNA 4833404L02 gene |
1755 |
0.2 |
chr16_55819320_55820037 | 16.92 |
Nfkbiz |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, zeta |
1163 |
0.48 |
chr1_51288641_51290950 | 16.31 |
Cavin2 |
caveolae associated 2 |
669 |
0.72 |
chr12_85175336_85177579 | 16.27 |
Pgf |
placental growth factor |
183 |
0.91 |
chr4_97868552_97869863 | 15.87 |
Nfia |
nuclear factor I/A |
10912 |
0.28 |
chr1_126683644_126684284 | 15.43 |
Nckap5 |
NCK-associated protein 5 |
54226 |
0.18 |
chr6_55617797_55618517 | 15.35 |
Neurod6 |
neurogenic differentiation 6 |
63106 |
0.11 |
chr12_54197224_54198192 | 15.28 |
Egln3 |
egl-9 family hypoxia-inducible factor 3 |
6152 |
0.19 |
chr10_86302733_86303435 | 15.13 |
Timp3 |
tissue inhibitor of metalloproteinase 3 |
230 |
0.95 |
chr6_136873814_136874977 | 15.11 |
Mgp |
matrix Gla protein |
1386 |
0.26 |
chr1_172501767_172503923 | 14.78 |
Tagln2 |
transgelin 2 |
1593 |
0.22 |
chr11_70227468_70228210 | 14.55 |
Bcl6b |
B cell CLL/lymphoma 6, member B |
1838 |
0.14 |
chr7_49247685_49248635 | 14.49 |
Nav2 |
neuron navigator 2 |
1315 |
0.51 |
chr17_71195611_71195988 | 14.34 |
Lpin2 |
lipin 2 |
8855 |
0.17 |
chr2_148441004_148443557 | 14.15 |
Cd93 |
CD93 antigen |
1283 |
0.41 |
chr7_142474634_142476734 | 14.13 |
Lsp1 |
lymphocyte specific 1 |
690 |
0.52 |
chr1_134232926_134233818 | 13.72 |
Adora1 |
adenosine A1 receptor |
1206 |
0.39 |
chr5_64045421_64045972 | 13.62 |
5830416I19Rik |
RIKEN cDNA 5830416I19 gene |
718 |
0.61 |
chr15_77021062_77022444 | 13.57 |
Mb |
myoglobin |
210 |
0.89 |
chr6_5992484_5992805 | 13.40 |
Dync1i1 |
dynein cytoplasmic 1 intermediate chain 1 |
13422 |
0.22 |
chr17_25077528_25081106 | 13.39 |
Tmem204 |
transmembrane protein 204 |
1093 |
0.35 |
chr3_138067510_138069146 | 13.32 |
Gm5105 |
predicted gene 5105 |
940 |
0.46 |
chr2_156778021_156779417 | 13.13 |
Myl9 |
myosin, light polypeptide 9, regulatory |
202 |
0.9 |
chr1_93159615_93160345 | 12.84 |
Mab21l4 |
mab-21-like 4 |
890 |
0.47 |
chr6_51844040_51844803 | 12.81 |
Skap2 |
src family associated phosphoprotein 2 |
27508 |
0.2 |
chr19_36116426_36116907 | 12.76 |
Ankrd1 |
ankyrin repeat domain 1 (cardiac muscle) |
3244 |
0.25 |
chr1_34120973_34122005 | 12.75 |
Dst |
dystonin |
239 |
0.92 |
chr6_135362982_135365483 | 12.61 |
Emp1 |
epithelial membrane protein 1 |
1164 |
0.42 |
chr7_19082814_19086200 | 12.58 |
Dmpk |
dystrophia myotonica-protein kinase |
203 |
0.83 |
chr10_80584595_80587584 | 12.54 |
Abhd17a |
abhydrolase domain containing 17A |
535 |
0.53 |
chr7_133088553_133089391 | 12.45 |
Ctbp2 |
C-terminal binding protein 2 |
22819 |
0.14 |
chr6_124717857_124719000 | 12.42 |
Mir200c |
microRNA 200c |
38 |
0.7 |
chr2_71690584_71691283 | 12.27 |
Platr26 |
pluripotency associated transcript 26 |
28484 |
0.13 |
chr16_77593904_77594384 | 12.27 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
222 |
0.87 |
chr7_17060653_17061482 | 12.23 |
Hif3a |
hypoxia inducible factor 3, alpha subunit |
1317 |
0.27 |
chr5_74197172_74198949 | 12.04 |
Rasl11b |
RAS-like, family 11, member B |
169 |
0.94 |
chr9_21183634_21184964 | 11.86 |
Pde4a |
phosphodiesterase 4A, cAMP specific |
196 |
0.89 |
chr13_48551952_48553040 | 11.84 |
6720427I07Rik |
RIKEN cDNA 6720427I07 gene |
5996 |
0.09 |
chr19_15996837_15997609 | 11.65 |
C130060C02Rik |
RIKEN cDNA C130060C02 gene |
12145 |
0.16 |
chr8_56979524_56979758 | 11.59 |
Gm7328 |
predicted gene 7328 |
26812 |
0.23 |
chrX_75047074_75047513 | 11.56 |
Gm15367 |
predicted gene 15367 |
36703 |
0.08 |
chr13_92274349_92274874 | 11.54 |
Msh3 |
mutS homolog 3 |
8539 |
0.22 |
chr7_31053809_31054516 | 11.52 |
Fxyd1 |
FXYD domain-containing ion transport regulator 1 |
117 |
0.91 |
chrX_73483606_73484999 | 11.49 |
Bgn |
biglycan |
663 |
0.59 |
chr8_77214627_77214991 | 11.32 |
Gm23260 |
predicted gene, 23260 |
20114 |
0.19 |
chr6_140666694_140667187 | 11.28 |
Aebp2 |
AE binding protein 2 |
20123 |
0.18 |
chr5_77114491_77115416 | 11.25 |
Hopx |
HOP homeobox |
168 |
0.93 |
chr19_27066722_27067039 | 11.14 |
Gm35438 |
predicted gene, 35438 |
35817 |
0.17 |
chr5_119804344_119805024 | 11.01 |
1700021F13Rik |
RIKEN cDNA 1700021F13 gene |
2983 |
0.24 |
chr3_151762523_151763341 | 10.96 |
Ifi44l |
interferon-induced protein 44 like |
40 |
0.98 |
chr3_27988009_27988450 | 10.86 |
Pld1 |
phospholipase D1 |
4056 |
0.32 |
chr19_47319497_47320713 | 10.82 |
Sh3pxd2a |
SH3 and PX domains 2A |
5354 |
0.2 |
chr4_141766580_141767172 | 10.81 |
Dnajc16 |
DnaJ heat shock protein family (Hsp40) member C16 |
7777 |
0.12 |
chr19_47136957_47138509 | 10.72 |
Calhm2 |
calcium homeostasis modulator family member 2 |
561 |
0.6 |
chr6_29434692_29436459 | 10.72 |
Flnc |
filamin C, gamma |
2299 |
0.16 |
chrX_152178908_152179528 | 10.71 |
Iqsec2 |
IQ motif and Sec7 domain 2 |
254 |
0.93 |
chr1_43730564_43731336 | 10.66 |
Ecrg4 |
ECRG4 augurin precursor |
348 |
0.83 |
chr3_9173586_9174576 | 10.65 |
Zbtb10 |
zinc finger and BTB domain containing 10 |
76521 |
0.09 |
chr15_6231364_6231664 | 10.61 |
Dab2 |
disabled 2, mitogen-responsive phosphoprotein |
68274 |
0.1 |
chr12_108370973_108372659 | 10.40 |
Eml1 |
echinoderm microtubule associated protein like 1 |
859 |
0.58 |
chr15_97750022_97751088 | 10.34 |
Rapgef3 |
Rap guanine nucleotide exchange factor (GEF) 3 |
150 |
0.93 |
chr3_85186481_85187125 | 10.34 |
Gm38313 |
predicted gene, 38313 |
9644 |
0.24 |
chr9_44136029_44136582 | 10.29 |
Mcam |
melanoma cell adhesion molecule |
239 |
0.78 |
chr3_119498694_119499278 | 10.28 |
Gm23432 |
predicted gene, 23432 |
139888 |
0.05 |
chr5_46033018_46033485 | 10.23 |
4930405L22Rik |
RIKEN cDNA 4930405L22 gene |
100842 |
0.07 |
chr5_21391725_21392143 | 10.21 |
Fgl2 |
fibrinogen-like protein 2 |
19292 |
0.16 |
chr1_161713119_161713350 | 10.17 |
Gm37638 |
predicted gene, 37638 |
471 |
0.79 |
chr19_59541762_59542770 | 10.11 |
Gm18161 |
predicted gene, 18161 |
1815 |
0.38 |
chr12_80687709_80688198 | 10.06 |
Plekhd1os |
pleckstrin homology domain containing, family D (with coiled-coil domains) member 1, opposite strand |
4513 |
0.12 |
chr1_20923283_20923475 | 10.04 |
Paqr8 |
progestin and adipoQ receptor family member VIII |
1120 |
0.39 |
chr3_138069501_138070764 | 10.03 |
1110002E22Rik |
RIKEN cDNA 1110002E22 gene |
1465 |
0.3 |
chr3_79885722_79887545 | 9.99 |
Gm36569 |
predicted gene, 36569 |
173 |
0.83 |
chr15_85654048_85654569 | 9.97 |
Lncppara |
long noncoding RNA near Ppara |
692 |
0.63 |
chr5_112289337_112289517 | 9.94 |
Tpst2 |
protein-tyrosine sulfotransferase 2 |
665 |
0.57 |
chr2_66783826_66785264 | 9.94 |
Scn7a |
sodium channel, voltage-gated, type VII, alpha |
369 |
0.91 |
chr9_56416072_56416694 | 9.86 |
Gm36940 |
predicted gene, 36940 |
317 |
0.81 |
chr8_11077134_11077834 | 9.75 |
B830042I05Rik |
RIKEN cDNA B830042I05 gene |
6438 |
0.16 |
chr2_85049940_85051247 | 9.73 |
Tnks1bp1 |
tankyrase 1 binding protein 1 |
15 |
0.96 |
chr1_37687354_37687813 | 9.66 |
Gm19863 |
predicted gene, 19863 |
9081 |
0.17 |
chr7_27332330_27333261 | 9.61 |
Ltbp4 |
latent transforming growth factor beta binding protein 4 |
818 |
0.46 |
chr5_119838900_119840891 | 9.61 |
Tbx5 |
T-box 5 |
3740 |
0.21 |
chr9_121950447_121951756 | 9.59 |
Gask1a |
golgi associated kinase 1A |
66 |
0.94 |
chr19_24851908_24852192 | 9.59 |
Gm50342 |
predicted gene, 50342 |
4146 |
0.18 |
chr1_164797487_164798003 | 9.57 |
Dpt |
dermatopontin |
1101 |
0.48 |
chr2_127728515_127728972 | 9.56 |
Mall |
mal, T cell differentiation protein-like |
1189 |
0.38 |
chr3_27316895_27317871 | 9.50 |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
322 |
0.89 |
chr5_67669613_67669824 | 9.49 |
Atp8a1 |
ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1 |
9684 |
0.14 |
chr16_32660648_32662499 | 9.47 |
Tnk2 |
tyrosine kinase, non-receptor, 2 |
321 |
0.85 |
chr6_5991750_5992420 | 9.45 |
Dync1i1 |
dynein cytoplasmic 1 intermediate chain 1 |
13981 |
0.22 |
chr6_112459682_112460792 | 9.41 |
Cav3 |
caveolin 3 |
732 |
0.65 |
chr16_33891656_33892607 | 9.36 |
Itgb5 |
integrin beta 5 |
184 |
0.95 |
chr12_71047764_71048612 | 9.33 |
Arid4a |
AT rich interactive domain 4A (RBP1-like) |
153 |
0.95 |
chr16_44691780_44692130 | 9.32 |
Nepro |
nucleolus and neural progenitor protein |
32346 |
0.15 |
chr2_26590270_26591404 | 9.31 |
Egfl7 |
EGF-like domain 7 |
128 |
0.75 |
chr6_115984719_115988278 | 9.29 |
Plxnd1 |
plexin D1 |
8507 |
0.15 |
chr9_121792003_121792549 | 9.29 |
Hhatl |
hedgehog acyltransferase-like |
231 |
0.84 |
chr9_109039786_109041652 | 9.26 |
Shisa5 |
shisa family member 5 |
113 |
0.92 |
chr13_78483236_78483924 | 9.23 |
Gm32067 |
predicted gene, 32067 |
226 |
0.95 |
chr7_70718275_70718796 | 9.21 |
Gm24880 |
predicted gene, 24880 |
33881 |
0.17 |
chr3_130337608_130338322 | 9.21 |
Gm22682 |
predicted gene, 22682 |
132500 |
0.04 |
chr10_61536234_61536857 | 9.20 |
Gm17829 |
predicted gene, 17829 |
25960 |
0.1 |
chr8_40863729_40864362 | 9.18 |
Slc7a2 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 |
1467 |
0.34 |
chr2_4517290_4517753 | 9.18 |
Frmd4a |
FERM domain containing 4A |
42233 |
0.14 |
chr8_34300393_34300887 | 9.17 |
Gm23177 |
predicted gene, 23177 |
4664 |
0.15 |
chr11_94498570_94500249 | 9.17 |
Epn3 |
epsin 3 |
289 |
0.85 |
chr15_101134186_101136364 | 9.15 |
Acvrl1 |
activin A receptor, type II-like 1 |
382 |
0.77 |
chr3_94372701_94373986 | 9.15 |
Rorc |
RAR-related orphan receptor gamma |
549 |
0.5 |
chr10_94709737_94709888 | 9.14 |
Cep83 |
centrosomal protein 83 |
21094 |
0.13 |
chr18_38281065_38284356 | 9.09 |
Pcdh12 |
protocadherin 12 |
1647 |
0.2 |
chr1_107590023_107591215 | 9.06 |
Serpinb8 |
serine (or cysteine) peptidase inhibitor, clade B, member 8 |
573 |
0.79 |
chr9_49975997_49976748 | 9.01 |
Gm47543 |
predicted gene, 47543 |
21494 |
0.25 |
chr15_76460831_76462844 | 9.00 |
Scx |
scleraxis |
4317 |
0.09 |
chr12_107010953_107011720 | 8.99 |
Gm16087 |
predicted gene 16087 |
55408 |
0.13 |
chr9_121415792_121416669 | 8.98 |
Trak1 |
trafficking protein, kinesin binding 1 |
255 |
0.92 |
chr7_28377585_28377954 | 8.97 |
Gm44710 |
predicted gene 44710 |
1211 |
0.2 |
chr15_32243133_32243485 | 8.96 |
Snhg18 |
small nucleolar RNA host gene 18 |
1353 |
0.26 |
chr1_90842678_90843968 | 8.96 |
Col6a3 |
collagen, type VI, alpha 3 |
605 |
0.7 |
chr2_85060620_85061523 | 8.96 |
Tnks1bp1 |
tankyrase 1 binding protein 1 |
107 |
0.95 |
chr4_29117917_29118116 | 8.95 |
Gm11918 |
predicted gene 11918 |
7930 |
0.22 |
chr6_113166557_113167183 | 8.93 |
Lhfpl4 |
lipoma HMGIC fusion partner-like protein 4 |
27073 |
0.12 |
chr1_74067852_74069114 | 8.92 |
Tns1 |
tensin 1 |
22868 |
0.17 |
chr11_65267588_65267984 | 8.89 |
Myocd |
myocardin |
2068 |
0.35 |
chr7_66831051_66831536 | 8.85 |
Adamts17 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 17 |
8442 |
0.22 |
chr16_77500388_77501627 | 8.84 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
623 |
0.62 |
chr6_72740543_72741436 | 8.82 |
Gm37736 |
predicted gene, 37736 |
10925 |
0.15 |
chr18_32523729_32523998 | 8.82 |
Gypc |
glycophorin C |
11555 |
0.17 |
chr1_75399614_75401197 | 8.81 |
Speg |
SPEG complex locus |
116 |
0.93 |
chr18_56683237_56683459 | 8.80 |
Gm50289 |
predicted gene, 50289 |
15570 |
0.16 |
chr10_81411418_81412636 | 8.77 |
Gm16104 |
predicted gene 16104 |
2452 |
0.09 |
chr11_59138835_59139238 | 8.74 |
Obscn |
obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF |
134 |
0.94 |
chr6_135087644_135088445 | 8.70 |
Gprc5a |
G protein-coupled receptor, family C, group 5, member A |
22393 |
0.12 |
chr6_49096738_49097482 | 8.70 |
Igf2bp3 |
insulin-like growth factor 2 mRNA binding protein 3 |
2899 |
0.16 |
chr19_5821858_5822796 | 8.67 |
Gm27702 |
predicted gene, 27702 |
2380 |
0.12 |
chr3_93556581_93556832 | 8.61 |
S100a10 |
S100 calcium binding protein A10 (calpactin) |
1543 |
0.28 |
chr9_53402629_53402979 | 8.60 |
4930550C14Rik |
RIKEN cDNA 4930550C14 gene |
479 |
0.73 |
chr16_42808952_42809103 | 8.60 |
4932412D23Rik |
RIKEN cDNA 4932412D23 gene |
66560 |
0.11 |
chr7_142576289_142578620 | 8.60 |
H19 |
H19, imprinted maternally expressed transcript |
68 |
0.78 |
chr2_91119045_91119896 | 8.57 |
Mybpc3 |
myosin binding protein C, cardiac |
1326 |
0.3 |
chr10_126982339_126984731 | 8.47 |
Ctdsp2 |
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 2 |
4506 |
0.09 |
chr1_134332594_134333240 | 8.44 |
Ppfia4 |
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4 |
11 |
0.97 |
chr6_137935280_137935834 | 8.43 |
Gm24308 |
predicted gene, 24308 |
15586 |
0.26 |
chr3_138075158_138075612 | 8.42 |
1110002E22Rik |
RIKEN cDNA 1110002E22 gene |
3788 |
0.16 |
chr11_97338178_97339372 | 8.40 |
Gpr179 |
G protein-coupled receptor 179 |
13241 |
0.12 |
chr4_34337418_34338131 | 8.38 |
Gm12751 |
predicted gene 12751 |
16269 |
0.2 |
chr6_128399389_128400934 | 8.37 |
Nrip2 |
nuclear receptor interacting protein 2 |
113 |
0.78 |
chr14_100558318_100558736 | 8.36 |
Gm49237 |
predicted gene, 49237 |
105 |
0.97 |
chr1_167270235_167270673 | 8.35 |
Uck2 |
uridine-cytidine kinase 2 |
14147 |
0.11 |
chr3_144759885_144761021 | 8.32 |
Clca3a1 |
chloride channel accessory 3A1 |
388 |
0.78 |
chr13_39183853_39184126 | 8.31 |
Slc35b3 |
solute carrier family 35, member B3 |
223114 |
0.02 |
chr10_89351234_89351657 | 8.30 |
Ano4 |
anoctamin 4 |
6683 |
0.29 |
chr15_81802115_81803592 | 8.29 |
Tef |
thyrotroph embryonic factor |
27 |
0.75 |
chr10_81426043_81427197 | 8.28 |
Nfic |
nuclear factor I/C |
494 |
0.54 |
chr5_119834833_119836185 | 8.27 |
Tbx5 |
T-box 5 |
646 |
0.68 |
chr12_99570151_99570727 | 8.27 |
4930556H04Rik |
RIKEN cDNA 4930556H04 gene |
699 |
0.41 |
chr13_96797589_96797740 | 8.26 |
Ankrd31 |
ankyrin repeat domain 31 |
11068 |
0.18 |
chr17_78895619_78895881 | 8.23 |
Sult6b1 |
sulfotransferase family, cytosolic, 6B, member 1 |
650 |
0.57 |
chr4_63744706_63745224 | 8.21 |
Tnfsf15 |
tumor necrosis factor (ligand) superfamily, member 15 |
148 |
0.96 |
chr9_58309544_58310675 | 8.21 |
Loxl1 |
lysyl oxidase-like 1 |
3077 |
0.21 |
chr5_139956998_139957418 | 8.15 |
Gm43704 |
predicted gene 43704 |
6583 |
0.19 |
chr12_103354203_103354890 | 8.13 |
Asb2 |
ankyrin repeat and SOCS box-containing 2 |
1455 |
0.26 |
chr18_55258362_55259199 | 8.07 |
Gm22597 |
predicted gene, 22597 |
78940 |
0.09 |
chr10_20776929_20777274 | 8.05 |
Gm48651 |
predicted gene, 48651 |
20984 |
0.21 |
chr10_94829348_94830149 | 8.01 |
Plxnc1 |
plexin C1 |
202 |
0.93 |
chr10_111390057_111390351 | 8.00 |
Gm40761 |
predicted gene, 40761 |
53080 |
0.11 |
chr1_93159043_93159516 | 7.99 |
Mab21l4 |
mab-21-like 4 |
1591 |
0.28 |
chr10_45003197_45003606 | 7.97 |
Gm4795 |
predicted pseudogene 4795 |
2709 |
0.24 |
chr18_53525239_53525518 | 7.95 |
Prdm6 |
PR domain containing 6 |
9844 |
0.28 |
chr18_33803754_33804261 | 7.92 |
Epb41l4a |
erythrocyte membrane protein band 4.1 like 4a |
909 |
0.58 |
chr2_167690537_167691384 | 7.88 |
A530013C23Rik |
RIKEN cDNA A530013C23 gene |
217 |
0.84 |
chr4_130047268_130048497 | 7.87 |
Col16a1 |
collagen, type XVI, alpha 1 |
3 |
0.59 |
chr1_152129958_152130681 | 7.86 |
Gm8964 |
predicted gene 8964 |
1734 |
0.45 |
chr2_118112796_118113528 | 7.86 |
Thbs1 |
thrombospondin 1 |
1286 |
0.33 |
chr5_125139990_125141281 | 7.85 |
Ncor2 |
nuclear receptor co-repressor 2 |
15735 |
0.2 |
chr2_61576966_61577405 | 7.83 |
Tank |
TRAF family member-associated Nf-kappa B activator |
1400 |
0.54 |
chr5_30013022_30013316 | 7.70 |
Il6 |
interleukin 6 |
1 |
0.97 |
chr7_105480803_105482499 | 7.70 |
Gm45667 |
predicted gene 45667 |
276 |
0.72 |
chr10_80347716_80349512 | 7.68 |
Adamtsl5 |
ADAMTS-like 5 |
202 |
0.82 |
chr9_68888905_68889137 | 7.68 |
Rora |
RAR-related orphan receptor alpha |
233718 |
0.02 |
chr16_31617897_31618941 | 7.65 |
Gm536 |
predicted gene 536 |
286 |
0.89 |
chr8_31713475_31713919 | 7.64 |
Gm5117 |
predicted gene 5117 |
26063 |
0.22 |
chr4_43399011_43400247 | 7.63 |
Rusc2 |
RUN and SH3 domain containing 2 |
1609 |
0.28 |
chr4_120161120_120162185 | 7.63 |
Edn2 |
endothelin 2 |
446 |
0.87 |
chr11_85995030_85996078 | 7.61 |
Gm11443 |
predicted gene 11443 |
45059 |
0.15 |
chr10_107930315_107930872 | 7.61 |
Gm29685 |
predicted gene, 29685 |
16052 |
0.22 |
chr15_102101516_102101972 | 7.59 |
Tns2 |
tensin 2 |
484 |
0.69 |
chr19_23497289_23497440 | 7.57 |
Mamdc2 |
MAM domain containing 2 |
48922 |
0.12 |
chr2_156776920_156777878 | 7.56 |
Myl9 |
myosin, light polypeptide 9, regulatory |
1118 |
0.36 |
chr2_27079055_27080577 | 7.55 |
Adamtsl2 |
ADAMTS-like 2 |
437 |
0.73 |
chr4_82622580_82622863 | 7.55 |
Gm11268 |
predicted gene 11268 |
19679 |
0.19 |
chr4_156058523_156059788 | 7.54 |
Ttll10 |
tubulin tyrosine ligase-like family, member 10 |
189 |
0.76 |
chr3_103736860_103738443 | 7.52 |
Olfml3 |
olfactomedin-like 3 |
317 |
0.76 |
chr2_118761554_118762997 | 7.48 |
Ccdc9b |
coiled-coil domain containing 9B |
350 |
0.79 |
chr3_151912204_151912402 | 7.46 |
Gm25056 |
predicted gene, 25056 |
14106 |
0.15 |
chr10_105284220_105284597 | 7.45 |
Tmtc2 |
transmembrane and tetratricopeptide repeat containing 2 |
49459 |
0.13 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.6 | 16.8 | GO:0021564 | vagus nerve development(GO:0021564) |
5.0 | 15.1 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
5.0 | 14.9 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
4.4 | 13.2 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
3.8 | 15.1 | GO:0035995 | detection of muscle stretch(GO:0035995) |
3.8 | 11.3 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
3.7 | 14.7 | GO:0060486 | Clara cell differentiation(GO:0060486) |
3.5 | 13.8 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
3.4 | 10.1 | GO:0036166 | phenotypic switching(GO:0036166) |
3.4 | 13.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
3.3 | 9.8 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
3.2 | 9.5 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
3.1 | 9.3 | GO:0006533 | aspartate catabolic process(GO:0006533) |
3.1 | 3.1 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
3.0 | 6.0 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
3.0 | 11.9 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
2.9 | 8.7 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
2.9 | 14.4 | GO:1904424 | regulation of GTP binding(GO:1904424) |
2.8 | 8.5 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
2.8 | 8.3 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
2.7 | 18.9 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
2.6 | 13.1 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
2.6 | 5.2 | GO:0065001 | specification of axis polarity(GO:0065001) |
2.6 | 18.0 | GO:0007021 | tubulin complex assembly(GO:0007021) |
2.6 | 10.3 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
2.5 | 10.2 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
2.4 | 7.3 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
2.4 | 4.8 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
2.4 | 14.4 | GO:0042118 | endothelial cell activation(GO:0042118) |
2.4 | 7.2 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
2.4 | 9.5 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
2.3 | 4.7 | GO:2000591 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
2.3 | 6.9 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
2.3 | 2.3 | GO:0060435 | bronchiole development(GO:0060435) |
2.3 | 6.9 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
2.3 | 6.8 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
2.2 | 6.7 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
2.2 | 6.7 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
2.2 | 8.9 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
2.2 | 8.8 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
2.2 | 6.6 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
2.2 | 6.5 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
2.1 | 12.8 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
2.1 | 6.3 | GO:0060468 | prevention of polyspermy(GO:0060468) |
2.1 | 6.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
2.1 | 10.3 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
2.0 | 8.1 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
2.0 | 5.9 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
2.0 | 9.9 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
2.0 | 11.9 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
1.9 | 5.8 | GO:1903416 | response to glycoside(GO:1903416) |
1.9 | 5.8 | GO:1902566 | regulation of eosinophil degranulation(GO:0043309) regulation of eosinophil activation(GO:1902566) |
1.9 | 3.9 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
1.9 | 5.7 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
1.9 | 11.4 | GO:0015671 | oxygen transport(GO:0015671) |
1.9 | 5.6 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
1.9 | 9.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.8 | 3.7 | GO:0006808 | regulation of nitrogen utilization(GO:0006808) |
1.8 | 5.5 | GO:1990123 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
1.8 | 9.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
1.8 | 7.2 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
1.8 | 9.0 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
1.8 | 5.3 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
1.7 | 5.2 | GO:0007494 | midgut development(GO:0007494) |
1.7 | 7.0 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
1.7 | 5.2 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
1.7 | 6.9 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
1.7 | 6.9 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
1.7 | 5.2 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
1.7 | 3.4 | GO:1902837 | amino acid import into cell(GO:1902837) |
1.7 | 1.7 | GO:0048769 | sarcomerogenesis(GO:0048769) |
1.7 | 5.0 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
1.6 | 3.3 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
1.6 | 8.1 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
1.6 | 1.6 | GO:0070640 | vitamin D3 metabolic process(GO:0070640) |
1.6 | 3.2 | GO:0003166 | bundle of His development(GO:0003166) |
1.6 | 4.8 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
1.6 | 1.6 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
1.6 | 4.7 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
1.6 | 4.7 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
1.5 | 3.1 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
1.5 | 7.7 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
1.5 | 4.6 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
1.5 | 4.5 | GO:2000338 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
1.5 | 10.5 | GO:2001028 | positive regulation of endothelial cell chemotaxis(GO:2001028) |
1.5 | 4.5 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
1.5 | 10.4 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
1.5 | 1.5 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
1.5 | 2.9 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
1.5 | 4.4 | GO:0015889 | cobalamin transport(GO:0015889) |
1.4 | 13.0 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
1.4 | 14.3 | GO:0032060 | bleb assembly(GO:0032060) |
1.4 | 2.9 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
1.4 | 2.8 | GO:0060437 | lung growth(GO:0060437) |
1.4 | 5.6 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
1.4 | 2.8 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
1.4 | 4.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
1.4 | 11.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
1.4 | 5.5 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
1.4 | 9.5 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
1.3 | 5.4 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
1.3 | 26.6 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
1.3 | 1.3 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
1.3 | 2.6 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.3 | 2.6 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
1.3 | 6.4 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) |
1.3 | 3.8 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
1.3 | 6.3 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
1.3 | 5.0 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.3 | 5.0 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
1.2 | 3.7 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
1.2 | 3.7 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
1.2 | 1.2 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
1.2 | 3.7 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
1.2 | 4.9 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
1.2 | 11.0 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
1.2 | 3.6 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.2 | 2.4 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
1.2 | 2.4 | GO:1905065 | positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
1.2 | 3.6 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
1.2 | 4.8 | GO:0045345 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
1.2 | 3.6 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
1.2 | 8.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
1.2 | 2.3 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
1.2 | 3.5 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
1.2 | 2.3 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
1.1 | 3.4 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
1.1 | 2.3 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
1.1 | 4.6 | GO:0030578 | PML body organization(GO:0030578) |
1.1 | 1.1 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
1.1 | 6.8 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
1.1 | 1.1 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
1.1 | 8.9 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
1.1 | 4.4 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
1.1 | 3.3 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
1.1 | 6.5 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
1.1 | 4.3 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
1.1 | 1.1 | GO:0050904 | diapedesis(GO:0050904) |
1.1 | 7.5 | GO:0032353 | negative regulation of hormone biosynthetic process(GO:0032353) |
1.1 | 5.3 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
1.1 | 5.3 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) |
1.0 | 1.0 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
1.0 | 2.1 | GO:0086013 | membrane repolarization during cardiac muscle cell action potential(GO:0086013) |
1.0 | 3.1 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
1.0 | 3.1 | GO:0014891 | striated muscle atrophy(GO:0014891) |
1.0 | 2.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
1.0 | 7.2 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
1.0 | 1.0 | GO:0003161 | cardiac conduction system development(GO:0003161) |
1.0 | 4.0 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
1.0 | 1.0 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
1.0 | 4.0 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
1.0 | 1.0 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
1.0 | 3.0 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
1.0 | 3.0 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
1.0 | 5.0 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
1.0 | 3.0 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
1.0 | 4.9 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
1.0 | 2.9 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
1.0 | 2.0 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
1.0 | 1.9 | GO:0001692 | histamine metabolic process(GO:0001692) |
1.0 | 4.8 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.9 | 4.7 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.9 | 4.7 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.9 | 4.7 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.9 | 3.8 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.9 | 4.7 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.9 | 2.8 | GO:0014741 | negative regulation of muscle hypertrophy(GO:0014741) |
0.9 | 8.5 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.9 | 2.8 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.9 | 6.6 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.9 | 3.8 | GO:0002159 | desmosome assembly(GO:0002159) |
0.9 | 2.8 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.9 | 0.9 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.9 | 1.9 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.9 | 2.7 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.9 | 2.7 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.9 | 5.4 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.9 | 1.8 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.9 | 2.7 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.9 | 0.9 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.9 | 1.8 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.9 | 12.5 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.9 | 1.8 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.9 | 0.9 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.9 | 4.4 | GO:0019532 | oxalate transport(GO:0019532) |
0.9 | 2.6 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.9 | 1.7 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.9 | 16.5 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.9 | 2.6 | GO:0001757 | somite specification(GO:0001757) |
0.9 | 2.6 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.9 | 6.9 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.9 | 2.6 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.9 | 2.6 | GO:0007525 | somatic muscle development(GO:0007525) |
0.9 | 2.6 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.9 | 3.4 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.8 | 4.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.8 | 2.5 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.8 | 1.7 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.8 | 2.5 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.8 | 2.5 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.8 | 3.3 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.8 | 3.3 | GO:0060283 | negative regulation of oocyte development(GO:0060283) |
0.8 | 2.5 | GO:0048143 | astrocyte activation(GO:0048143) |
0.8 | 10.6 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.8 | 13.9 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.8 | 1.6 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.8 | 1.6 | GO:0003163 | sinoatrial node development(GO:0003163) |
0.8 | 2.4 | GO:0060214 | endocardium formation(GO:0060214) |
0.8 | 2.4 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.8 | 0.8 | GO:0072093 | metanephric renal vesicle formation(GO:0072093) |
0.8 | 5.5 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
0.8 | 3.9 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.8 | 2.3 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.8 | 9.3 | GO:0014850 | response to muscle activity(GO:0014850) |
0.8 | 2.3 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.8 | 5.4 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.8 | 0.8 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.8 | 1.5 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.8 | 2.3 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.8 | 3.1 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.8 | 0.8 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.8 | 3.8 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.8 | 1.5 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.8 | 0.8 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.8 | 3.0 | GO:0048539 | bone marrow development(GO:0048539) |
0.7 | 2.2 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.7 | 3.7 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.7 | 2.2 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.7 | 5.9 | GO:0090195 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) |
0.7 | 1.5 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.7 | 2.9 | GO:0030091 | protein repair(GO:0030091) |
0.7 | 1.5 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.7 | 0.7 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
0.7 | 1.5 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.7 | 5.1 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.7 | 26.0 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.7 | 0.7 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.7 | 2.2 | GO:0003207 | cardiac chamber formation(GO:0003207) |
0.7 | 1.4 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.7 | 7.8 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.7 | 5.0 | GO:0006108 | malate metabolic process(GO:0006108) |
0.7 | 1.4 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.7 | 0.7 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.7 | 2.1 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.7 | 0.7 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
0.7 | 6.2 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.7 | 2.1 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.7 | 5.4 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.7 | 4.7 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.7 | 2.0 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.7 | 2.7 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.7 | 8.6 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.7 | 2.0 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.7 | 2.0 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.7 | 2.0 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.7 | 3.9 | GO:0060613 | fat pad development(GO:0060613) |
0.7 | 1.3 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.7 | 1.3 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.7 | 3.9 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.7 | 3.3 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.6 | 7.8 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.6 | 12.9 | GO:0035329 | hippo signaling(GO:0035329) |
0.6 | 2.6 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.6 | 2.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.6 | 1.3 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.6 | 4.4 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.6 | 2.5 | GO:0019695 | choline metabolic process(GO:0019695) |
0.6 | 4.4 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.6 | 1.9 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.6 | 1.9 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.6 | 11.8 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.6 | 2.5 | GO:0032252 | secretory granule localization(GO:0032252) |
0.6 | 0.6 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.6 | 2.5 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.6 | 3.0 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.6 | 1.2 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.6 | 1.8 | GO:0051794 | regulation of catagen(GO:0051794) |
0.6 | 1.2 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.6 | 1.8 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.6 | 1.8 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.6 | 1.8 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) regulation of endodermal cell differentiation(GO:1903224) |
0.6 | 1.8 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.6 | 0.6 | GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) |
0.6 | 3.6 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.6 | 3.0 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.6 | 3.0 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.6 | 1.2 | GO:0003093 | regulation of glomerular filtration(GO:0003093) |
0.6 | 1.2 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.6 | 2.4 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.6 | 5.8 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.6 | 4.1 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.6 | 4.1 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.6 | 1.7 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.6 | 1.2 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.6 | 2.3 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.6 | 5.8 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.6 | 2.3 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.6 | 0.6 | GO:0048340 | paraxial mesoderm morphogenesis(GO:0048340) |
0.6 | 1.1 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.6 | 4.6 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.6 | 4.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.6 | 3.4 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.6 | 2.8 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.6 | 1.7 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) positive regulation of blood vessel remodeling(GO:2000504) |
0.6 | 3.4 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.6 | 5.7 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.6 | 1.7 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.6 | 16.9 | GO:0006073 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.6 | 0.6 | GO:0042321 | negative regulation of circadian sleep/wake cycle, sleep(GO:0042321) |
0.6 | 1.7 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.6 | 1.1 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.6 | 0.6 | GO:0072262 | metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
0.6 | 23.4 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.6 | 0.6 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.6 | 1.1 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.6 | 0.6 | GO:0045649 | regulation of macrophage differentiation(GO:0045649) positive regulation of macrophage differentiation(GO:0045651) |
0.6 | 1.1 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) |
0.6 | 2.8 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.6 | 2.8 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.6 | 1.1 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.5 | 1.6 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.5 | 3.8 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.5 | 4.9 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.5 | 1.1 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.5 | 3.8 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.5 | 1.6 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.5 | 2.1 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.5 | 5.9 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.5 | 1.6 | GO:0060296 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.5 | 3.7 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.5 | 3.7 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.5 | 0.5 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.5 | 5.9 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.5 | 3.7 | GO:0060056 | mammary gland involution(GO:0060056) |
0.5 | 1.1 | GO:0003383 | apical constriction(GO:0003383) |
0.5 | 1.6 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.5 | 0.5 | GO:0045606 | positive regulation of epidermal cell differentiation(GO:0045606) |
0.5 | 1.1 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.5 | 2.7 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.5 | 0.5 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.5 | 1.6 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.5 | 0.5 | GO:0035910 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) cell-cell signaling involved in cell fate commitment(GO:0045168) pharyngeal arch artery morphogenesis(GO:0061626) |
0.5 | 1.6 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.5 | 5.8 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.5 | 0.5 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.5 | 0.5 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.5 | 2.6 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.5 | 0.5 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.5 | 0.5 | GO:0071671 | monocyte extravasation(GO:0035696) regulation of smooth muscle cell chemotaxis(GO:0071671) positive regulation of smooth muscle cell chemotaxis(GO:0071673) regulation of monocyte extravasation(GO:2000437) |
0.5 | 1.6 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.5 | 1.6 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.5 | 2.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.5 | 1.6 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.5 | 1.6 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.5 | 0.5 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.5 | 1.5 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.5 | 1.5 | GO:0097048 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.5 | 1.0 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.5 | 1.5 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.5 | 1.0 | GO:0090335 | regulation of brown fat cell differentiation(GO:0090335) |
0.5 | 2.6 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.5 | 0.5 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.5 | 5.6 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.5 | 0.5 | GO:2001026 | regulation of endothelial cell chemotaxis(GO:2001026) |
0.5 | 12.7 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.5 | 2.0 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.5 | 0.5 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.5 | 0.5 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.5 | 1.5 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.5 | 3.0 | GO:0030575 | nuclear body organization(GO:0030575) |
0.5 | 2.0 | GO:0051639 | actin filament network formation(GO:0051639) |
0.5 | 6.0 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.5 | 1.5 | GO:0014028 | notochord formation(GO:0014028) |
0.5 | 1.5 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.5 | 1.0 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.5 | 2.5 | GO:0018158 | protein oxidation(GO:0018158) |
0.5 | 2.9 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.5 | 1.9 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.5 | 1.0 | GO:0002934 | desmosome organization(GO:0002934) |
0.5 | 2.9 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.5 | 2.4 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.5 | 0.5 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.5 | 1.9 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.5 | 2.4 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.5 | 0.5 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.5 | 0.5 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.5 | 1.4 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.5 | 0.9 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.5 | 0.9 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.5 | 0.9 | GO:0060534 | trachea cartilage development(GO:0060534) |
0.5 | 2.3 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.5 | 0.5 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.5 | 1.4 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.5 | 1.4 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.5 | 0.5 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.5 | 1.8 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.5 | 4.5 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.5 | 0.5 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.5 | 11.7 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
0.4 | 17.0 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.4 | 7.6 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.4 | 4.0 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.4 | 3.6 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.4 | 0.4 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
0.4 | 0.4 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.4 | 4.4 | GO:2000778 | positive regulation of interleukin-6 secretion(GO:2000778) |
0.4 | 0.9 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
0.4 | 5.3 | GO:0032743 | positive regulation of interleukin-2 production(GO:0032743) |
0.4 | 1.8 | GO:0015867 | ATP transport(GO:0015867) |
0.4 | 1.3 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.4 | 0.4 | GO:0031650 | regulation of heat generation(GO:0031650) |
0.4 | 3.1 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.4 | 0.9 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.4 | 10.8 | GO:0043149 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.4 | 0.4 | GO:0002604 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) |
0.4 | 1.3 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.4 | 0.9 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.4 | 0.4 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.4 | 2.6 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.4 | 0.4 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.4 | 0.8 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.4 | 0.8 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.4 | 39.4 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.4 | 0.4 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
0.4 | 2.5 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.4 | 1.7 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.4 | 0.8 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.4 | 0.8 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.4 | 0.8 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.4 | 1.2 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.4 | 0.8 | GO:0015810 | aspartate transport(GO:0015810) |
0.4 | 0.4 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.4 | 0.8 | GO:0035360 | regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035358) positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.4 | 0.4 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.4 | 1.2 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.4 | 1.2 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.4 | 1.6 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.4 | 0.4 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.4 | 2.0 | GO:0006112 | energy reserve metabolic process(GO:0006112) |
0.4 | 0.8 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.4 | 4.4 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.4 | 9.3 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.4 | 0.4 | GO:2000858 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
0.4 | 0.8 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.4 | 2.7 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.4 | 1.9 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.4 | 0.4 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.4 | 1.5 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.4 | 1.1 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.4 | 1.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.4 | 0.4 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
0.4 | 1.1 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.4 | 2.6 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.4 | 1.9 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.4 | 1.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.4 | 1.5 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.4 | 1.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.4 | 1.1 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.4 | 1.9 | GO:0030903 | notochord development(GO:0030903) |
0.4 | 1.9 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
0.4 | 1.1 | GO:0042891 | antibiotic transport(GO:0042891) |
0.4 | 1.1 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.4 | 0.7 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.4 | 0.7 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.4 | 1.5 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.4 | 0.7 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.4 | 0.4 | GO:0036257 | multivesicular body organization(GO:0036257) |
0.4 | 1.1 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.4 | 1.1 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.4 | 1.8 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.4 | 0.4 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.4 | 0.4 | GO:1904833 | positive regulation of superoxide dismutase activity(GO:1901671) positive regulation of removal of superoxide radicals(GO:1904833) |
0.4 | 0.4 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.4 | 0.4 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.4 | 1.1 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.3 | 1.7 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.3 | 0.7 | GO:2000834 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.3 | 0.3 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.3 | 0.7 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.3 | 0.7 | GO:0046959 | habituation(GO:0046959) |
0.3 | 0.7 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.3 | 1.0 | GO:0071476 | cellular hypotonic response(GO:0071476) |
0.3 | 0.7 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.3 | 0.7 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
0.3 | 0.7 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.3 | 1.0 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.3 | 1.0 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.3 | 1.0 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.3 | 1.0 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.3 | 0.3 | GO:0046321 | positive regulation of fatty acid oxidation(GO:0046321) |
0.3 | 1.7 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.3 | 0.7 | GO:2000726 | negative regulation of cardiac muscle cell differentiation(GO:2000726) |
0.3 | 0.3 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.3 | 2.7 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.3 | 0.3 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.3 | 1.0 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.3 | 10.3 | GO:0070527 | platelet aggregation(GO:0070527) |
0.3 | 4.6 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.3 | 4.6 | GO:0060612 | adipose tissue development(GO:0060612) |
0.3 | 2.0 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.3 | 0.7 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.3 | 1.0 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.3 | 0.3 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.3 | 10.8 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.3 | 0.7 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.3 | 1.3 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.3 | 8.6 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.3 | 0.6 | GO:0097384 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.3 | 0.3 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.3 | 1.0 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.3 | 1.6 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.3 | 0.3 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.3 | 1.6 | GO:0010543 | regulation of platelet activation(GO:0010543) |
0.3 | 1.3 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.3 | 1.6 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.3 | 9.4 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.3 | 3.8 | GO:0002040 | sprouting angiogenesis(GO:0002040) |
0.3 | 3.5 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.3 | 0.3 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.3 | 0.6 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.3 | 0.9 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.3 | 0.6 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.3 | 2.2 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.3 | 0.6 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.3 | 0.9 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.3 | 2.2 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.3 | 0.6 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.3 | 0.9 | GO:0009173 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.3 | 1.8 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.3 | 0.6 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.3 | 0.3 | GO:0002034 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.3 | 0.6 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.3 | 1.5 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.3 | 2.4 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.3 | 5.1 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.3 | 0.3 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.3 | 0.9 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.3 | 1.2 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.3 | 1.2 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.3 | 0.9 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.3 | 1.5 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.3 | 1.5 | GO:0030432 | peristalsis(GO:0030432) |
0.3 | 1.5 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.3 | 0.6 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.3 | 0.9 | GO:0010560 | positive regulation of glycoprotein biosynthetic process(GO:0010560) |
0.3 | 0.6 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.3 | 0.3 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.3 | 0.9 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.3 | 0.9 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.3 | 0.6 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.3 | 1.2 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.3 | 2.9 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.3 | 0.6 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.3 | 0.3 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.3 | 0.9 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.3 | 1.2 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.3 | 1.4 | GO:0016266 | O-glycan processing(GO:0016266) |
0.3 | 0.6 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.3 | 2.3 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.3 | 0.6 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.3 | 2.0 | GO:0060438 | trachea development(GO:0060438) |
0.3 | 0.3 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.3 | 2.0 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.3 | 0.3 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.3 | 1.7 | GO:0097320 | membrane tubulation(GO:0097320) |
0.3 | 3.0 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.3 | 0.6 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.3 | 3.0 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.3 | 0.3 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.3 | 0.8 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.3 | 2.2 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.3 | 0.5 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.3 | 0.5 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.3 | 0.8 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.3 | 0.5 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.3 | 0.3 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.3 | 5.7 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.3 | 1.6 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.3 | 2.2 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.3 | 0.5 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.3 | 0.3 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.3 | 0.5 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.3 | 0.3 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
0.3 | 0.5 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.3 | 4.0 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.3 | 0.8 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.3 | 0.3 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.3 | 0.5 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.3 | 0.3 | GO:0071622 | regulation of granulocyte chemotaxis(GO:0071622) |
0.3 | 0.5 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
0.3 | 0.5 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.3 | 0.3 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.3 | 1.0 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.3 | 2.6 | GO:0003334 | keratinocyte development(GO:0003334) |
0.3 | 0.8 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.3 | 1.3 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.3 | 5.4 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.3 | 0.8 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.3 | 0.8 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.3 | 0.5 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.3 | 3.6 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.3 | 1.0 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.3 | 0.5 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.3 | 2.0 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.3 | 4.0 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.3 | 0.5 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.3 | 0.8 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.2 | 0.5 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.2 | 1.2 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.2 | 0.5 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.2 | 1.2 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.2 | 5.4 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.2 | 0.2 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.2 | 1.0 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.2 | 1.2 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.2 | 1.2 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.2 | 0.2 | GO:0090427 | activation of meiosis(GO:0090427) |
0.2 | 0.2 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.2 | 0.7 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.2 | 0.2 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.2 | 1.7 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.2 | 1.2 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.2 | 16.7 | GO:0098792 | xenophagy(GO:0098792) |
0.2 | 0.2 | GO:0048295 | interleukin-4-mediated signaling pathway(GO:0035771) positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.2 | 1.2 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 1.2 | GO:0042148 | strand invasion(GO:0042148) |
0.2 | 0.5 | GO:0051182 | coenzyme transport(GO:0051182) |
0.2 | 0.5 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.2 | 0.2 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.2 | 0.7 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.2 | 0.5 | GO:0070570 | regulation of neuron projection regeneration(GO:0070570) |
0.2 | 0.5 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.2 | 0.9 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.2 | 0.5 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.2 | 0.5 | GO:0045714 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.2 | 0.7 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.2 | 0.7 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.2 | 0.5 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.2 | 0.2 | GO:0061074 | regulation of neural retina development(GO:0061074) |
0.2 | 0.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.2 | 1.8 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.2 | 0.5 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.2 | 0.5 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.2 | 0.2 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.2 | 2.5 | GO:0051642 | centrosome localization(GO:0051642) |
0.2 | 0.2 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.2 | 0.7 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.2 | 1.8 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.2 | 1.1 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.2 | 2.0 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.2 | 0.9 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.2 | 0.4 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.2 | 0.7 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.2 | 2.4 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.2 | 0.4 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
0.2 | 2.6 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.2 | 0.9 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.2 | 0.6 | GO:0042523 | positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
0.2 | 0.9 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.2 | 0.2 | GO:0033622 | integrin activation(GO:0033622) |
0.2 | 0.4 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.2 | 0.6 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.2 | 0.8 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 0.4 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.2 | 0.4 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.2 | 0.4 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.2 | 0.2 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.2 | 1.0 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.2 | 0.8 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.2 | 0.2 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.2 | 4.6 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.2 | 0.4 | GO:0072711 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.2 | 0.4 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.2 | 1.0 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
0.2 | 0.4 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.2 | 0.8 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.2 | 0.4 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.2 | 1.6 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.2 | 1.2 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.2 | 0.2 | GO:0050932 | regulation of pigment cell differentiation(GO:0050932) |
0.2 | 0.2 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.2 | 0.6 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.2 | 0.2 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.2 | 0.2 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.2 | 0.6 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.2 | 0.2 | GO:1903365 | regulation of fear response(GO:1903365) regulation of behavioral fear response(GO:2000822) |
0.2 | 0.4 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.2 | 0.2 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.2 | 0.6 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 0.8 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.2 | 2.1 | GO:0008272 | sulfate transport(GO:0008272) |
0.2 | 1.6 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.2 | 0.8 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.2 | 0.4 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.2 | 1.0 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.2 | 0.2 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.2 | 1.5 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.2 | 1.3 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.2 | 1.1 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.2 | 0.9 | GO:0018101 | protein citrullination(GO:0018101) |
0.2 | 1.7 | GO:0070166 | enamel mineralization(GO:0070166) |
0.2 | 4.3 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.2 | 1.1 | GO:0007144 | female meiosis I(GO:0007144) |
0.2 | 3.2 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.2 | 0.4 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.2 | 0.5 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.2 | 0.7 | GO:0018119 | peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.2 | 2.0 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.2 | 0.5 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.2 | 0.4 | GO:0033084 | immature T cell proliferation in thymus(GO:0033080) regulation of immature T cell proliferation in thymus(GO:0033084) |
0.2 | 0.4 | GO:0019230 | proprioception(GO:0019230) |
0.2 | 0.9 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.2 | 0.2 | GO:0070671 | response to interleukin-12(GO:0070671) |
0.2 | 0.5 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.2 | 0.2 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.2 | 0.5 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.2 | 0.5 | GO:0070242 | thymocyte apoptotic process(GO:0070242) |
0.2 | 0.7 | GO:0071800 | podosome assembly(GO:0071800) |
0.2 | 0.2 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.2 | 0.5 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.2 | 0.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.2 | 0.2 | GO:0072203 | cell proliferation involved in metanephros development(GO:0072203) |
0.2 | 0.7 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 0.2 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
0.2 | 0.2 | GO:0036394 | amylase secretion(GO:0036394) |
0.2 | 0.7 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.2 | 0.3 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.2 | 0.5 | GO:0008228 | opsonization(GO:0008228) |
0.2 | 1.7 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 1.7 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.2 | 1.2 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.2 | 0.5 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.2 | 0.5 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.2 | 0.7 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 0.3 | GO:0021764 | amygdala development(GO:0021764) |
0.2 | 0.8 | GO:0070842 | aggresome assembly(GO:0070842) |
0.2 | 0.8 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.2 | 0.3 | GO:0060022 | hard palate development(GO:0060022) |
0.2 | 0.5 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.2 | 0.8 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 0.3 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.2 | 0.6 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.2 | 0.2 | GO:0071220 | response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) |
0.2 | 1.0 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.2 | 0.5 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.2 | 0.3 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.2 | 1.6 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.2 | 0.2 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.2 | 0.2 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.2 | 0.2 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.2 | 0.3 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.2 | 1.5 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.2 | 0.6 | GO:0001927 | exocyst assembly(GO:0001927) |
0.2 | 0.5 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
0.2 | 1.2 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.2 | 0.5 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 0.2 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.2 | 4.1 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.2 | 0.2 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.2 | 0.6 | GO:0001945 | lymph vessel development(GO:0001945) |
0.2 | 0.3 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) |
0.2 | 0.2 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.2 | 4.5 | GO:0045576 | mast cell activation(GO:0045576) |
0.2 | 0.3 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.1 | 0.4 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.1 | 0.1 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 1.8 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 0.3 | GO:0007567 | parturition(GO:0007567) |
0.1 | 1.2 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.7 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 0.7 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 1.0 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 1.6 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.1 | 2.1 | GO:1901343 | negative regulation of vasculature development(GO:1901343) negative regulation of blood vessel morphogenesis(GO:2000181) |
0.1 | 0.1 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.1 | 0.8 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.1 | 0.1 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.1 | 0.3 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 0.6 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.1 | 0.6 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 9.7 | GO:0030198 | extracellular matrix organization(GO:0030198) |
0.1 | 3.5 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.1 | 0.3 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.1 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.1 | 0.4 | GO:0021756 | striatum development(GO:0021756) |
0.1 | 0.3 | GO:0033058 | directional locomotion(GO:0033058) |
0.1 | 0.6 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.1 | 0.1 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.1 | 0.1 | GO:1904180 | negative regulation of membrane depolarization(GO:1904180) |
0.1 | 0.4 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.1 | 0.3 | GO:0034333 | adherens junction assembly(GO:0034333) |
0.1 | 0.3 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 0.1 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.1 | 0.7 | GO:0060180 | female mating behavior(GO:0060180) |
0.1 | 0.1 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.1 | 0.5 | GO:0071715 | icosanoid transport(GO:0071715) fatty acid derivative transport(GO:1901571) |
0.1 | 0.5 | GO:0015824 | proline transport(GO:0015824) |
0.1 | 1.3 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
0.1 | 0.9 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.1 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.1 | 0.5 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 1.6 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.1 | 0.4 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.1 | 0.1 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.1 | 0.6 | GO:0061377 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.1 | 0.6 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 3.5 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.1 | 0.1 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 0.1 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.1 | 0.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 1.0 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 1.1 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 0.1 | GO:0021888 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
0.1 | 2.5 | GO:0035082 | axoneme assembly(GO:0035082) |
0.1 | 0.4 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.1 | 0.1 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 0.9 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 2.1 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 1.4 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.1 | 0.5 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 2.5 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.6 | GO:0042311 | vasodilation(GO:0042311) |
0.1 | 1.3 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.1 | 0.1 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.1 | 0.2 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.4 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
0.1 | 0.2 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.1 | 0.4 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.1 | 0.4 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.1 | 0.5 | GO:0014075 | response to amine(GO:0014075) |
0.1 | 0.1 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.1 | 0.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.1 | 0.2 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.1 | 1.1 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 1.2 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 0.4 | GO:0051031 | tRNA transport(GO:0051031) |
0.1 | 0.3 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 0.7 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.1 | 0.2 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.1 | 0.1 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.3 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.3 | GO:0051608 | histamine transport(GO:0051608) |
0.1 | 1.0 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.1 | 0.3 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
0.1 | 0.3 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.2 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 0.2 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 0.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.1 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.1 | 0.4 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.1 | 0.1 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.1 | 0.1 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.1 | 3.3 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.1 | 0.1 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.1 | 0.2 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) |
0.1 | 0.1 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.2 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.5 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.1 | 1.8 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.1 | 0.1 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.1 | 0.6 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.5 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.2 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.1 | 0.2 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.1 | 0.4 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.1 | 0.1 | GO:0046958 | nonassociative learning(GO:0046958) |
0.1 | 0.7 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 0.9 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.4 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 0.3 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.4 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.1 | 1.3 | GO:0048678 | response to axon injury(GO:0048678) |
0.1 | 0.1 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.1 | 0.6 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.1 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.1 | 0.1 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 0.1 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.1 | 0.6 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 0.3 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.1 | 0.4 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 0.2 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.2 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.1 | 0.1 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.1 | 0.1 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.1 | 0.1 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.1 | 0.3 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.1 | 0.5 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.3 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.1 | 0.3 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.1 | GO:0097186 | amelogenesis(GO:0097186) |
0.1 | 0.3 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 0.1 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.1 | 0.2 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 0.1 | GO:1902896 | terminal web assembly(GO:1902896) |
0.1 | 0.1 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 0.5 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 0.2 | GO:0001759 | organ induction(GO:0001759) |
0.1 | 0.3 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 2.4 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) |
0.1 | 0.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.1 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.1 | 0.6 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) |
0.1 | 1.0 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.1 | 1.6 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 1.8 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
0.1 | 0.1 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.1 | 0.3 | GO:0051900 | regulation of mitochondrial depolarization(GO:0051900) |
0.1 | 0.3 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.1 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 0.6 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.1 | 0.4 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.9 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.4 | GO:0030033 | microvillus assembly(GO:0030033) |
0.1 | 0.1 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.1 | 0.7 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.1 | 0.7 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.1 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.1 | 0.4 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.1 | GO:0070673 | response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
0.1 | 0.1 | GO:1902170 | cellular response to reactive nitrogen species(GO:1902170) |
0.1 | 0.1 | GO:0035590 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 0.5 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 1.0 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.1 | 0.3 | GO:0030857 | negative regulation of epithelial cell differentiation(GO:0030857) |
0.1 | 0.5 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.1 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.1 | 2.6 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.1 | 0.5 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.7 | GO:0009812 | flavonoid metabolic process(GO:0009812) flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.1 | 0.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.1 | 0.2 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 0.1 | GO:1900226 | macrophage inflammatory protein-1 alpha production(GO:0071608) negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.1 | 0.8 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.1 | 0.3 | GO:0014047 | glutamate secretion(GO:0014047) |
0.1 | 0.2 | GO:0071047 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.1 | 0.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 0.1 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.1 | 0.2 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.1 | 0.3 | GO:0002029 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
0.1 | 0.1 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.1 | 0.3 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.2 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.1 | 0.1 | GO:0035948 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.1 | 0.1 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.1 | 0.1 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.1 | 1.9 | GO:0007566 | embryo implantation(GO:0007566) |
0.1 | 0.2 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.1 | 0.4 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.1 | 2.5 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.1 | 0.1 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.1 | 0.1 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.1 | 0.1 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.1 | 0.2 | GO:0015888 | thiamine transport(GO:0015888) |
0.1 | 0.1 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.1 | 0.1 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.1 | 0.7 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.1 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.5 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.1 | 0.1 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
0.1 | 0.2 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.2 | GO:0002155 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.1 | 0.1 | GO:0046490 | isopentenyl diphosphate metabolic process(GO:0046490) |
0.1 | 0.1 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.1 | 0.3 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.1 | 0.1 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.1 | 0.5 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.1 | GO:0060027 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) convergent extension involved in gastrulation(GO:0060027) convergent extension involved in organogenesis(GO:0060029) |
0.1 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.3 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.1 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.1 | 0.2 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 0.1 | GO:0051665 | membrane raft localization(GO:0051665) |
0.1 | 0.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.1 | GO:0002418 | immune response to tumor cell(GO:0002418) |
0.1 | 0.9 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 0.2 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.0 | 0.0 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.0 | 0.5 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.0 | 0.1 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.0 | 0.2 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.0 | 0.0 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.0 | 0.5 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.0 | 0.2 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.0 | 0.0 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.0 | 0.1 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 0.0 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.0 | 0.1 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.0 | 0.2 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.0 | 0.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.4 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.0 | 0.3 | GO:0060043 | regulation of cardiac muscle cell proliferation(GO:0060043) |
0.0 | 0.1 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.0 | 0.2 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.0 | 0.0 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.0 | 0.2 | GO:0045581 | negative regulation of T cell differentiation(GO:0045581) |
0.0 | 0.1 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.0 | 0.1 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.0 | 0.0 | GO:0060460 | left lung morphogenesis(GO:0060460) |
0.0 | 0.1 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.0 | 0.9 | GO:0090662 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.1 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.0 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.0 | 0.1 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.0 | 0.0 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.0 | 0.0 | GO:0002118 | aggressive behavior(GO:0002118) |
0.0 | 0.2 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.1 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.0 | 0.1 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.0 | 0.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.3 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.0 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.0 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.0 | 0.0 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.0 | 0.0 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.0 | 0.2 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.4 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.0 | GO:0034505 | tooth mineralization(GO:0034505) |
0.0 | 0.0 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.0 | 0.3 | GO:0010524 | positive regulation of calcium ion transport into cytosol(GO:0010524) |
0.0 | 0.1 | GO:0032891 | negative regulation of organic acid transport(GO:0032891) |
0.0 | 0.3 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.3 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.0 | 0.0 | GO:0031077 | post-embryonic camera-type eye development(GO:0031077) |
0.0 | 0.4 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.0 | 0.1 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.0 | 0.0 | GO:0042640 | anagen(GO:0042640) |
0.0 | 0.1 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.0 | 0.2 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.0 | 0.1 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.0 | 0.8 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.0 | 0.2 | GO:1904869 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.0 | 0.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.1 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.0 | GO:1900115 | sequestering of extracellular ligand from receptor(GO:0035581) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.0 | 0.3 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.0 | 0.1 | GO:0090148 | membrane fission(GO:0090148) |
0.0 | 0.2 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.0 | 0.1 | GO:1990266 | neutrophil migration(GO:1990266) |
0.0 | 0.0 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.0 | 0.0 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.0 | 0.2 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.0 | 0.1 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.0 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.0 | 0.4 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.0 | 0.0 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.0 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.1 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.0 | 0.1 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.0 | 0.0 | GO:0003094 | glomerular filtration(GO:0003094) |
0.0 | 0.8 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.0 | 0.2 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.7 | GO:0006941 | striated muscle contraction(GO:0006941) |
0.0 | 0.0 | GO:0086005 | ventricular cardiac muscle cell action potential(GO:0086005) |
0.0 | 0.0 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.0 | 0.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.0 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.0 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.0 | 0.0 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.0 | 0.1 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 0.0 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.0 | 0.0 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.0 | 0.0 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.0 | 0.0 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.0 | 0.1 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.0 | 0.0 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.0 | GO:0055006 | cardiac cell development(GO:0055006) |
0.0 | 0.0 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.0 | 0.1 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.0 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.0 | 0.1 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.0 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
0.0 | 0.0 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.1 | GO:0097576 | autophagosome maturation(GO:0097352) vacuole fusion(GO:0097576) |
0.0 | 0.0 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.0 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.0 | 0.2 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.0 | 0.1 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.0 | 0.0 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.0 | 0.0 | GO:0038001 | paracrine signaling(GO:0038001) |
0.0 | 0.5 | GO:0050913 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) sensory perception of bitter taste(GO:0050913) |
0.0 | 0.0 | GO:0002760 | positive regulation of antimicrobial humoral response(GO:0002760) |
0.0 | 0.0 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.9 | 23.7 | GO:0097512 | cardiac myofibril(GO:0097512) |
6.8 | 20.3 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
4.8 | 14.4 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
4.2 | 12.5 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
2.5 | 7.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
2.4 | 7.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
2.0 | 18.0 | GO:0097470 | ribbon synapse(GO:0097470) |
2.0 | 7.9 | GO:0005610 | laminin-5 complex(GO:0005610) |
1.9 | 3.9 | GO:0044393 | microspike(GO:0044393) |
1.9 | 26.7 | GO:0016460 | myosin II complex(GO:0016460) |
1.9 | 32.0 | GO:0005614 | interstitial matrix(GO:0005614) |
1.8 | 5.5 | GO:0097443 | sorting endosome(GO:0097443) |
1.7 | 6.8 | GO:0071953 | elastic fiber(GO:0071953) |
1.7 | 3.3 | GO:0043259 | laminin-10 complex(GO:0043259) |
1.7 | 16.6 | GO:0001527 | microfibril(GO:0001527) |
1.7 | 10.0 | GO:0030056 | hemidesmosome(GO:0030056) |
1.5 | 4.6 | GO:1990635 | proximal dendrite(GO:1990635) |
1.5 | 6.1 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
1.5 | 11.9 | GO:0005861 | troponin complex(GO:0005861) |
1.5 | 3.0 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
1.5 | 4.4 | GO:0032280 | symmetric synapse(GO:0032280) |
1.4 | 5.5 | GO:1990716 | axonemal central apparatus(GO:1990716) |
1.4 | 4.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
1.3 | 5.3 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
1.3 | 3.8 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
1.3 | 6.3 | GO:0005927 | muscle tendon junction(GO:0005927) |
1.2 | 1.2 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
1.2 | 4.9 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
1.2 | 1.2 | GO:0005606 | laminin-1 complex(GO:0005606) |
1.2 | 7.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.1 | 2.3 | GO:0043219 | lateral loop(GO:0043219) |
1.1 | 6.8 | GO:0005915 | zonula adherens(GO:0005915) |
1.1 | 9.6 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
1.1 | 50.6 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
1.1 | 8.4 | GO:0034464 | BBSome(GO:0034464) |
1.0 | 8.1 | GO:0042587 | glycogen granule(GO:0042587) |
1.0 | 4.0 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
1.0 | 7.9 | GO:0001520 | outer dense fiber(GO:0001520) |
1.0 | 5.9 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
1.0 | 80.6 | GO:0005604 | basement membrane(GO:0005604) |
1.0 | 2.9 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.9 | 2.8 | GO:0031983 | vesicle lumen(GO:0031983) |
0.9 | 16.5 | GO:0043218 | compact myelin(GO:0043218) |
0.9 | 2.7 | GO:1990393 | 3M complex(GO:1990393) |
0.9 | 6.2 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.9 | 13.2 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.8 | 11.0 | GO:0043034 | costamere(GO:0043034) |
0.8 | 3.3 | GO:0044299 | C-fiber(GO:0044299) |
0.8 | 9.2 | GO:0002102 | podosome(GO:0002102) |
0.7 | 7.4 | GO:0005916 | fascia adherens(GO:0005916) |
0.7 | 2.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.7 | 6.5 | GO:0097542 | ciliary tip(GO:0097542) |
0.7 | 5.0 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.7 | 2.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.7 | 1.4 | GO:0000322 | storage vacuole(GO:0000322) |
0.7 | 23.2 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.6 | 3.6 | GO:0032982 | myosin filament(GO:0032982) |
0.6 | 1.8 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.6 | 3.5 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.6 | 3.5 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.6 | 1.2 | GO:0043511 | inhibin complex(GO:0043511) |
0.6 | 1.8 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.6 | 1.2 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.6 | 5.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.6 | 140.7 | GO:0031012 | extracellular matrix(GO:0031012) |
0.5 | 5.5 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.5 | 10.2 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.5 | 1.1 | GO:0030478 | actin cap(GO:0030478) |
0.5 | 37.6 | GO:0005901 | caveola(GO:0005901) |
0.5 | 1.6 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.5 | 5.8 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.5 | 1.6 | GO:0031430 | M band(GO:0031430) |
0.5 | 7.8 | GO:0014704 | intercalated disc(GO:0014704) |
0.5 | 10.6 | GO:0008305 | integrin complex(GO:0008305) |
0.5 | 4.5 | GO:0020003 | symbiont-containing vacuole(GO:0020003) extracellular membrane-bounded organelle(GO:0065010) |
0.5 | 1.5 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.5 | 1.5 | GO:0043293 | apoptosome(GO:0043293) |
0.5 | 0.5 | GO:0044292 | dendrite terminus(GO:0044292) |
0.5 | 0.9 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.5 | 4.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.4 | 1.3 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.4 | 0.4 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.4 | 1.7 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.4 | 5.4 | GO:0036038 | MKS complex(GO:0036038) |
0.4 | 7.1 | GO:0000242 | pericentriolar material(GO:0000242) |
0.4 | 30.6 | GO:0031674 | I band(GO:0031674) |
0.4 | 0.4 | GO:0042583 | chromaffin granule(GO:0042583) |
0.4 | 1.6 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.4 | 6.0 | GO:0030057 | desmosome(GO:0030057) |
0.4 | 1.2 | GO:0042588 | zymogen granule(GO:0042588) |
0.4 | 0.4 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.4 | 0.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.4 | 6.1 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.4 | 4.5 | GO:0097386 | glial cell projection(GO:0097386) |
0.4 | 2.9 | GO:0060091 | kinocilium(GO:0060091) |
0.4 | 5.8 | GO:0030673 | axolemma(GO:0030673) |
0.4 | 1.4 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.4 | 1.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.4 | 3.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 1.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.3 | 28.8 | GO:0043296 | apical junction complex(GO:0043296) |
0.3 | 3.1 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.3 | 0.7 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.3 | 1.4 | GO:0033643 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.3 | 4.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.3 | 2.7 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.3 | 3.0 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.3 | 0.7 | GO:0031523 | Myb complex(GO:0031523) |
0.3 | 0.3 | GO:1904949 | ATPase complex(GO:1904949) |
0.3 | 1.0 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.3 | 0.6 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.3 | 1.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.3 | 6.6 | GO:0032420 | stereocilium(GO:0032420) |
0.3 | 1.9 | GO:0031143 | pseudopodium(GO:0031143) |
0.3 | 0.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.3 | 2.7 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.3 | 0.3 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.3 | 2.4 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.3 | 1.8 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 5.2 | GO:0005922 | connexon complex(GO:0005922) |
0.3 | 23.5 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.3 | 0.3 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.3 | 12.0 | GO:0043292 | contractile fiber(GO:0043292) |
0.3 | 0.6 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.3 | 1.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.3 | 1.9 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.3 | 0.8 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.3 | 60.6 | GO:0030055 | cell-substrate junction(GO:0030055) |
0.3 | 0.5 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.3 | 1.1 | GO:0042629 | mast cell granule(GO:0042629) |
0.3 | 0.8 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.3 | 1.3 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.3 | 7.9 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.2 | 1.0 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.2 | 12.3 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.2 | 0.2 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.2 | 1.2 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.2 | 1.9 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.2 | 1.4 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 0.2 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.2 | 1.4 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.2 | 0.5 | GO:0035838 | growing cell tip(GO:0035838) |
0.2 | 0.4 | GO:0005955 | calcineurin complex(GO:0005955) |
0.2 | 0.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 3.8 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 1.3 | GO:0016589 | NURF complex(GO:0016589) |
0.2 | 1.9 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.2 | 1.9 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 0.4 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.2 | 0.6 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.2 | 0.6 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 1.2 | GO:0033391 | chromatoid body(GO:0033391) |
0.2 | 0.4 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.2 | 0.4 | GO:0033270 | paranode region of axon(GO:0033270) |
0.2 | 7.2 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 1.0 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.2 | 1.1 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.2 | 0.8 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 0.6 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.2 | 1.3 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 0.4 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.2 | 1.3 | GO:0071546 | pi-body(GO:0071546) |
0.2 | 0.2 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.2 | 0.2 | GO:0036396 | MIS complex(GO:0036396) |
0.2 | 0.4 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.2 | 0.2 | GO:0032432 | actin filament bundle(GO:0032432) |
0.2 | 1.3 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.2 | 0.4 | GO:0097546 | ciliary base(GO:0097546) |
0.2 | 0.7 | GO:0045298 | tubulin complex(GO:0045298) |
0.2 | 1.8 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 1.7 | GO:0051233 | spindle midzone(GO:0051233) |
0.2 | 2.1 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.2 | 5.4 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.2 | 0.5 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.2 | 3.3 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 5.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 0.7 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 1.0 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.2 | 1.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 1.5 | GO:0005912 | adherens junction(GO:0005912) |
0.2 | 0.2 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.2 | 1.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 0.8 | GO:0000796 | condensin complex(GO:0000796) |
0.2 | 1.0 | GO:0070847 | core mediator complex(GO:0070847) |
0.2 | 0.6 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.2 | 1.4 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.2 | 0.9 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.2 | 0.6 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.2 | 0.2 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 0.8 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.2 | 0.9 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.2 | 2.1 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.2 | 0.5 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.2 | 1.8 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.2 | 0.6 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.4 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 0.4 | GO:1990357 | terminal web(GO:1990357) |
0.1 | 0.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.4 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 9.2 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.4 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 0.7 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.4 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.1 | 1.9 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.5 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 1.1 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 1.4 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.1 | 0.4 | GO:0042585 | germinal vesicle(GO:0042585) |
0.1 | 7.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.8 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 12.5 | GO:0005911 | cell-cell junction(GO:0005911) |
0.1 | 1.3 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 5.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 4.0 | GO:0072372 | primary cilium(GO:0072372) |
0.1 | 2.5 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.5 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.5 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.7 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 2.0 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 5.4 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.3 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 0.2 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.1 | 0.5 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 0.1 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.1 | 0.2 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.1 | 1.0 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.1 | 1.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.1 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 1.7 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 0.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 3.2 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 3.6 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.8 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 0.7 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 0.8 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.5 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.1 | 1.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 1.4 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 0.3 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 0.2 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 5.3 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 6.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.1 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.1 | 0.1 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.1 | 0.8 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.9 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 3.6 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 1.1 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 9.5 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 0.3 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 0.2 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 1.0 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.4 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 1.0 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 1.2 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.4 | GO:0043194 | axon initial segment(GO:0043194) |
0.1 | 0.1 | GO:0097433 | dense body(GO:0097433) |
0.1 | 1.7 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 69.6 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 0.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 4.7 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.1 | 0.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.2 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.5 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 3.6 | GO:0043235 | receptor complex(GO:0043235) |
0.1 | 1.3 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 0.3 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.1 | 0.3 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 3.2 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 1.0 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.1 | GO:0000235 | astral microtubule(GO:0000235) |
0.1 | 0.2 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 0.1 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.8 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.2 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 0.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.0 | 0.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.0 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 1.5 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 1.8 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 3.5 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 2.3 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.5 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.0 | 4.8 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.0 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.0 | 0.9 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 3.0 | GO:0005938 | cell cortex(GO:0005938) |
0.0 | 0.1 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.0 | 0.6 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.0 | 12.0 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 42.0 | GO:1903561 | extracellular vesicle(GO:1903561) |
0.0 | 0.0 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.0 | 0.1 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.0 | 0.0 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 0.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 5.3 | GO:0030054 | cell junction(GO:0030054) |
0.0 | 0.0 | GO:0030891 | VCB complex(GO:0030891) |
0.0 | 0.1 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 10.5 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.0 | 0.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.0 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 0.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.0 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.2 | GO:0000786 | nucleosome(GO:0000786) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 10.8 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
3.3 | 23.3 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
3.0 | 6.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
3.0 | 15.1 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
3.0 | 26.9 | GO:0031432 | titin binding(GO:0031432) |
2.9 | 29.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
2.8 | 11.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
2.6 | 7.7 | GO:0008142 | oxysterol binding(GO:0008142) |
2.6 | 7.7 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
2.4 | 12.2 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
2.3 | 16.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
2.2 | 6.6 | GO:0031433 | telethonin binding(GO:0031433) |
2.1 | 6.4 | GO:0070538 | oleic acid binding(GO:0070538) |
2.1 | 6.2 | GO:0048030 | disaccharide binding(GO:0048030) |
2.1 | 6.2 | GO:0045503 | dynein light chain binding(GO:0045503) |
2.1 | 12.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
2.0 | 10.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.9 | 11.4 | GO:0005344 | oxygen transporter activity(GO:0005344) |
1.8 | 24.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
1.7 | 5.2 | GO:0030172 | troponin C binding(GO:0030172) |
1.7 | 5.2 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
1.7 | 12.0 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
1.6 | 8.1 | GO:0048185 | activin binding(GO:0048185) |
1.6 | 17.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
1.6 | 15.9 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
1.6 | 6.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
1.5 | 3.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
1.5 | 7.4 | GO:1990239 | steroid hormone binding(GO:1990239) |
1.5 | 4.4 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
1.5 | 4.4 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
1.5 | 2.9 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
1.4 | 4.3 | GO:0031014 | troponin T binding(GO:0031014) |
1.4 | 4.2 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
1.4 | 4.2 | GO:0038181 | bile acid receptor activity(GO:0038181) |
1.4 | 5.5 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
1.4 | 6.9 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
1.3 | 4.0 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
1.3 | 2.6 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.3 | 3.9 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.3 | 3.9 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.3 | 15.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
1.3 | 11.7 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
1.3 | 3.9 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
1.3 | 3.8 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.3 | 7.7 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
1.2 | 16.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
1.2 | 7.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
1.2 | 2.4 | GO:0031013 | troponin I binding(GO:0031013) |
1.2 | 21.1 | GO:0005112 | Notch binding(GO:0005112) |
1.2 | 10.5 | GO:0017166 | vinculin binding(GO:0017166) |
1.1 | 5.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
1.1 | 4.5 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
1.1 | 3.4 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
1.1 | 3.3 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
1.1 | 4.4 | GO:0038064 | collagen receptor activity(GO:0038064) |
1.1 | 3.3 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
1.1 | 9.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
1.1 | 6.3 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
1.0 | 4.2 | GO:0030274 | LIM domain binding(GO:0030274) |
1.0 | 2.1 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
1.0 | 11.4 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
1.0 | 5.2 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
1.0 | 9.2 | GO:0038191 | neuropilin binding(GO:0038191) |
1.0 | 1.0 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
1.0 | 13.1 | GO:0005123 | death receptor binding(GO:0005123) |
1.0 | 2.9 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
1.0 | 4.8 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
1.0 | 3.9 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
1.0 | 2.9 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.9 | 1.9 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.9 | 2.8 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.9 | 9.3 | GO:0044548 | S100 protein binding(GO:0044548) |
0.9 | 0.9 | GO:0051373 | FATZ binding(GO:0051373) |
0.9 | 8.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.9 | 22.5 | GO:0004118 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.9 | 21.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.9 | 18.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.9 | 2.7 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.9 | 1.8 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.9 | 5.2 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.9 | 6.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.9 | 0.9 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.8 | 3.4 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.8 | 1.7 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.8 | 5.0 | GO:0038132 | neuregulin binding(GO:0038132) |
0.8 | 5.0 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.8 | 2.5 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.8 | 5.8 | GO:0003680 | AT DNA binding(GO:0003680) |
0.8 | 7.4 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.8 | 1.6 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.8 | 2.4 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.8 | 1.6 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.8 | 2.4 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.8 | 10.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.8 | 3.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.8 | 5.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.8 | 0.8 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.8 | 2.3 | GO:0004359 | glutaminase activity(GO:0004359) |
0.8 | 41.9 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.7 | 6.7 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.7 | 3.7 | GO:0043426 | MRF binding(GO:0043426) |
0.7 | 5.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.7 | 3.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.7 | 3.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.7 | 7.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.7 | 2.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.7 | 7.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.7 | 4.2 | GO:0042805 | actinin binding(GO:0042805) |
0.7 | 2.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.7 | 2.8 | GO:0035276 | ethanol binding(GO:0035276) |
0.7 | 2.0 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.7 | 52.6 | GO:0005178 | integrin binding(GO:0005178) |
0.7 | 3.4 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.7 | 2.0 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.7 | 11.3 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.7 | 4.0 | GO:0034902 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.7 | 2.6 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.7 | 1.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.6 | 1.3 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.6 | 3.9 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.6 | 1.9 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.6 | 3.2 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.6 | 16.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.6 | 5.7 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.6 | 22.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.6 | 1.9 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.6 | 3.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.6 | 8.0 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.6 | 2.5 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.6 | 0.6 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.6 | 1.8 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.6 | 3.0 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.6 | 2.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.6 | 1.7 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.6 | 2.8 | GO:0050544 | icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) |
0.6 | 9.4 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.6 | 7.2 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.5 | 1.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.5 | 2.7 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.5 | 14.2 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.5 | 2.7 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.5 | 2.2 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.5 | 2.7 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.5 | 5.9 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.5 | 13.6 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.5 | 8.8 | GO:0003785 | actin monomer binding(GO:0003785) |
0.5 | 5.7 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.5 | 1.5 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.5 | 14.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.5 | 2.0 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.5 | 1.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.5 | 6.0 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.5 | 4.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.5 | 0.5 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.5 | 9.3 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.5 | 1.5 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.5 | 1.5 | GO:0051870 | methotrexate binding(GO:0051870) |
0.5 | 1.0 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.5 | 0.5 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.5 | 4.3 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.5 | 2.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.5 | 5.6 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.5 | 2.3 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.5 | 2.8 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.5 | 5.6 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.5 | 1.4 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.5 | 3.3 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.5 | 2.3 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.5 | 1.8 | GO:0043495 | protein anchor(GO:0043495) |
0.5 | 1.4 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.5 | 14.6 | GO:0015485 | cholesterol binding(GO:0015485) |
0.5 | 5.0 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.5 | 3.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.5 | 1.8 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.4 | 2.2 | GO:0030552 | cAMP binding(GO:0030552) |
0.4 | 0.9 | GO:0018562 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.4 | 1.3 | GO:0030984 | kininogen binding(GO:0030984) |
0.4 | 1.3 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.4 | 1.3 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.4 | 1.3 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.4 | 10.5 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.4 | 1.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.4 | 0.9 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.4 | 2.6 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.4 | 1.7 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.4 | 4.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.4 | 1.3 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.4 | 2.9 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.4 | 0.8 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.4 | 2.0 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.4 | 1.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.4 | 3.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.4 | 1.2 | GO:0071253 | connexin binding(GO:0071253) |
0.4 | 3.5 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.4 | 1.6 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.4 | 0.8 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.4 | 1.2 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.4 | 35.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.4 | 6.9 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.4 | 4.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.4 | 3.8 | GO:0031005 | filamin binding(GO:0031005) |
0.4 | 0.7 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.4 | 1.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.4 | 0.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.4 | 1.1 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.4 | 7.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.4 | 1.5 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.4 | 0.7 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.4 | 2.9 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.4 | 2.9 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.4 | 4.3 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.4 | 2.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.4 | 0.7 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.4 | 0.4 | GO:0030487 | inositol-4,5-bisphosphate 5-phosphatase activity(GO:0030487) |
0.4 | 1.4 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.4 | 0.7 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.4 | 0.7 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.4 | 0.7 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.4 | 4.6 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.4 | 1.8 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.4 | 2.5 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.4 | 0.4 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.3 | 1.0 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.3 | 101.3 | GO:0003779 | actin binding(GO:0003779) |
0.3 | 1.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.3 | 6.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.3 | 6.2 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.3 | 4.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.3 | 8.5 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.3 | 1.7 | GO:0043762 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.3 | 1.3 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.3 | 1.0 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.3 | 1.7 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.3 | 1.3 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.3 | 0.7 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.3 | 1.0 | GO:0035939 | microsatellite binding(GO:0035939) |
0.3 | 1.0 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.3 | 1.6 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.3 | 1.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.3 | 1.0 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.3 | 0.7 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.3 | 1.6 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.3 | 2.2 | GO:0070513 | death domain binding(GO:0070513) |
0.3 | 1.3 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.3 | 0.6 | GO:2001070 | starch binding(GO:2001070) |
0.3 | 0.9 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.3 | 0.9 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.3 | 1.2 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.3 | 1.2 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.3 | 1.9 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.3 | 0.9 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.3 | 7.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.3 | 1.2 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.3 | 1.5 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.3 | 2.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.3 | 0.9 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.3 | 1.2 | GO:0031996 | thioesterase binding(GO:0031996) |
0.3 | 2.1 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.3 | 0.9 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.3 | 2.9 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.3 | 3.8 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.3 | 0.9 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.3 | 0.6 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.3 | 0.6 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.3 | 1.1 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.3 | 3.6 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.3 | 3.6 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.3 | 1.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.3 | 0.6 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.3 | 6.6 | GO:0050699 | WW domain binding(GO:0050699) |
0.3 | 0.8 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.3 | 0.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.3 | 0.3 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.3 | 0.8 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.3 | 1.9 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.3 | 0.5 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.3 | 0.3 | GO:0045340 | mercury ion binding(GO:0045340) |
0.3 | 0.8 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.3 | 1.6 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.3 | 1.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.3 | 3.9 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.3 | 0.5 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.3 | 2.3 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.3 | 7.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.3 | 0.5 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.3 | 5.4 | GO:0008483 | transaminase activity(GO:0008483) |
0.3 | 7.0 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.3 | 1.8 | GO:0051400 | BH domain binding(GO:0051400) |
0.3 | 0.8 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.3 | 1.0 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.3 | 4.8 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 0.7 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.2 | 0.5 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.2 | 1.0 | GO:0004031 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.2 | 0.7 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.2 | 0.2 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.2 | 0.5 | GO:0004096 | catalase activity(GO:0004096) |
0.2 | 6.3 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.2 | 1.2 | GO:0002054 | nucleobase binding(GO:0002054) |
0.2 | 0.5 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.2 | 20.2 | GO:0008201 | heparin binding(GO:0008201) |
0.2 | 1.7 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 3.8 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.2 | 2.4 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.2 | 0.5 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 2.3 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.2 | 1.2 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.2 | 0.5 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.2 | 3.5 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.2 | 2.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.2 | 3.9 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.2 | 6.7 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.2 | 0.7 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.2 | 1.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.2 | 0.9 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 0.7 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.2 | 2.0 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 0.7 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 0.2 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.2 | 0.9 | GO:0071814 | lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.2 | 0.7 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.2 | 1.5 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.2 | 3.0 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.2 | 0.6 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 2.4 | GO:0008932 | lytic endotransglycosylase activity(GO:0008932) |
0.2 | 0.4 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.2 | 11.2 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.2 | 0.6 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.2 | 0.6 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.2 | 0.4 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.2 | 4.1 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.2 | 0.8 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 0.4 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.2 | 1.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 1.8 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.2 | 0.2 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.2 | 0.6 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.2 | 4.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.2 | 0.8 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.2 | 1.6 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.2 | 0.4 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.2 | 0.2 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.2 | 2.4 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.2 | 1.0 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.2 | 1.0 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 9.3 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.2 | 0.6 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.2 | 1.4 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.2 | 0.8 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 0.6 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.2 | 0.6 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.2 | 0.2 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 1.9 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.2 | 0.2 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.2 | 0.9 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 0.2 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.2 | 0.6 | GO:0019808 | polyamine binding(GO:0019808) |
0.2 | 0.6 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.2 | 37.3 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.2 | 0.2 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.2 | 0.4 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.2 | 0.4 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 0.2 | GO:0050693 | LBD domain binding(GO:0050693) |
0.2 | 0.7 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.2 | 0.5 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 0.9 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.2 | 3.9 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.2 | 2.0 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.2 | 0.4 | GO:0035671 | enone reductase activity(GO:0035671) |
0.2 | 0.4 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.2 | 0.2 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.2 | 0.5 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.2 | 0.7 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.2 | 0.7 | GO:0030955 | potassium ion binding(GO:0030955) |
0.2 | 0.9 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.2 | 0.5 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.2 | 0.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 1.4 | GO:0031402 | sodium ion binding(GO:0031402) |
0.2 | 0.2 | GO:0008579 | JUN kinase phosphatase activity(GO:0008579) |
0.2 | 0.8 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.2 | 0.3 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.2 | 2.2 | GO:0008143 | poly(A) binding(GO:0008143) |
0.2 | 0.2 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.2 | 0.5 | GO:0005165 | neurotrophin receptor binding(GO:0005165) |
0.2 | 1.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 4.9 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.2 | 1.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.2 | 1.1 | GO:0000150 | recombinase activity(GO:0000150) |
0.2 | 4.7 | GO:0005507 | copper ion binding(GO:0005507) |
0.2 | 0.5 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.2 | 0.5 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.2 | 0.6 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.2 | 0.5 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.2 | 0.8 | GO:0030957 | Tat protein binding(GO:0030957) |
0.2 | 0.8 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.2 | 0.3 | GO:0032052 | bile acid binding(GO:0032052) |
0.2 | 0.6 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.2 | 0.9 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 0.9 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 0.5 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 0.8 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 1.1 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 0.5 | GO:0035473 | lipase binding(GO:0035473) |
0.2 | 2.3 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.1 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.1 | 0.7 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.4 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.1 | 0.7 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.1 | 0.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 2.6 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.6 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 1.1 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.9 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 2.3 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 2.9 | GO:0034840 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) mevaldate reductase activity(GO:0004495) gluconate dehydrogenase activity(GO:0008875) epoxide dehydrogenase activity(GO:0018451) 5-exo-hydroxycamphor dehydrogenase activity(GO:0018452) 2-hydroxytetrahydrofuran dehydrogenase activity(GO:0018453) acetoin dehydrogenase activity(GO:0019152) phenylcoumaran benzylic ether reductase activity(GO:0032442) D-xylose:NADP reductase activity(GO:0032866) L-arabinose:NADP reductase activity(GO:0032867) D-arabinitol dehydrogenase, D-ribulose forming (NADP+) activity(GO:0033709) (R)-(-)-1,2,3,4-tetrahydronaphthol dehydrogenase activity(GO:0034831) 3-hydroxymenthone dehydrogenase activity(GO:0034840) very long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0035380) dihydrotestosterone 17-beta-dehydrogenase activity(GO:0035410) (R)-2-hydroxyisocaproate dehydrogenase activity(GO:0043713) L-arabinose 1-dehydrogenase (NADP+) activity(GO:0044103) L-xylulose reductase (NAD+) activity(GO:0044105) 3-ketoglucose-reductase activity(GO:0048258) D-arabinitol dehydrogenase, D-xylulose forming (NADP+) activity(GO:0052677) |
0.1 | 0.4 | GO:0046030 | inositol trisphosphate phosphatase activity(GO:0046030) |
0.1 | 0.6 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 1.4 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 0.4 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 5.8 | GO:0008083 | growth factor activity(GO:0008083) |
0.1 | 0.4 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.9 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 0.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.1 | 2.7 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.1 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.1 | 1.3 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.1 | 0.2 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.1 | 0.4 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 0.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.1 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 2.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.2 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.7 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.6 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.1 | 0.4 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.5 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 0.7 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 0.1 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.1 | 3.2 | GO:0005496 | steroid binding(GO:0005496) |
0.1 | 1.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.1 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.1 | 0.3 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 1.2 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 1.0 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.1 | 0.1 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.1 | 0.1 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.1 | 0.6 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 0.4 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 12.1 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.3 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.1 | 0.6 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 1.8 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 0.3 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 2.7 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 0.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.4 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.1 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.1 | 0.1 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 3.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) calcium:cation antiporter activity(GO:0015368) |
0.1 | 0.1 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.1 | 0.2 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 2.4 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 5.1 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.1 | 0.3 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.1 | 0.5 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.4 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.1 | 1.0 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 0.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 2.7 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 0.3 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 0.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.3 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.1 | 0.3 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.7 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 1.6 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 0.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 0.2 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 0.7 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.2 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) sugar-phosphatase activity(GO:0050308) |
0.1 | 0.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.1 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.1 | 0.5 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 0.1 | GO:0035870 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
0.1 | 0.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.7 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.1 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.1 | 0.4 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 1.4 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.3 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 1.2 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.1 | 0.5 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 5.8 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 0.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.2 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 0.6 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.1 | 0.5 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 0.2 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 0.2 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 0.6 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.2 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 0.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 0.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.6 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.2 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 2.0 | GO:0070330 | aromatase activity(GO:0070330) |
0.1 | 0.1 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.1 | 0.8 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 3.1 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.4 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 3.6 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 2.0 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.1 | 0.5 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 1.6 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.1 | 0.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.2 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 0.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.9 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.2 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.3 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.5 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 1.7 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.1 | 0.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 0.3 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.6 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.1 | 0.3 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 0.3 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.1 | GO:0032934 | sterol binding(GO:0032934) |
0.1 | 0.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 0.3 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.9 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.0 | 8.8 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 0.1 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.0 | 0.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.0 | 0.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.3 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.1 | GO:0016208 | AMP binding(GO:0016208) |
0.0 | 2.4 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.0 | 0.1 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.0 | 0.0 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 0.3 | GO:0034868 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.0 | 2.0 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.0 | 0.0 | GO:0070696 | receptor serine/threonine kinase binding(GO:0033612) transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.0 | 0.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.3 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.1 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.1 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.8 | GO:0043914 | NADPH:sulfur oxidoreductase activity(GO:0043914) |
0.0 | 2.1 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.6 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 3.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.2 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 0.0 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.0 | 0.5 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.0 | 0.8 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.0 | 0.0 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 1.1 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.3 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.0 | 0.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.0 | 0.7 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.1 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.0 | 0.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.0 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.0 | 0.1 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.0 | 0.4 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.0 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 1.8 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.0 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.0 | 0.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.0 | 0.1 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.0 | 0.3 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.1 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.0 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.0 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.0 | GO:0070728 | leucine binding(GO:0070728) |
0.0 | 0.1 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.0 | 0.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.0 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.0 | 0.0 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.0 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.4 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.0 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.0 | 0.1 | GO:0005542 | folic acid binding(GO:0005542) |
0.0 | 0.0 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.0 | 0.0 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.5 | 31.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
1.6 | 17.6 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
1.5 | 65.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
1.3 | 40.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
1.3 | 1.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
1.2 | 1.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
1.1 | 4.3 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
1.1 | 16.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
1.1 | 47.2 | PID ILK PATHWAY | Integrin-linked kinase signaling |
1.0 | 25.1 | PID ALK1 PATHWAY | ALK1 signaling events |
1.0 | 12.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
1.0 | 7.8 | ST STAT3 PATHWAY | STAT3 Pathway |
0.9 | 11.8 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.9 | 11.9 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.8 | 25.4 | NABA COLLAGENS | Genes encoding collagen proteins |
0.8 | 0.8 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.8 | 10.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.8 | 14.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.8 | 7.8 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.8 | 22.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.8 | 19.0 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.8 | 10.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.7 | 2.9 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.7 | 1.5 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.7 | 5.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.7 | 3.5 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.7 | 18.6 | PID RAS PATHWAY | Regulation of Ras family activation |
0.7 | 6.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.7 | 21.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.7 | 2.0 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.6 | 11.0 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.6 | 1.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.6 | 3.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.6 | 0.6 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.6 | 14.3 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.6 | 18.3 | PID CDC42 PATHWAY | CDC42 signaling events |
0.6 | 4.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.6 | 2.3 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.6 | 1.7 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.6 | 2.3 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.6 | 12.2 | PID INSULIN PATHWAY | Insulin Pathway |
0.6 | 9.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.6 | 9.6 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.5 | 12.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.5 | 17.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.5 | 3.1 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.5 | 1.5 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.5 | 20.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.5 | 0.5 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.5 | 8.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.5 | 7.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.5 | 8.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.5 | 12.9 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.4 | 3.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.4 | 15.0 | PID ENDOTHELIN PATHWAY | Endothelins |
0.4 | 2.5 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.4 | 5.5 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.4 | 9.5 | PID FGF PATHWAY | FGF signaling pathway |
0.4 | 3.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.4 | 9.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.4 | 51.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.4 | 11.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.4 | 1.9 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.4 | 49.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.4 | 7.7 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.4 | 1.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.4 | 70.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.4 | 4.6 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.3 | 10.4 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.3 | 1.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.3 | 4.8 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.3 | 0.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.3 | 2.9 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.3 | 2.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.3 | 3.7 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.3 | 1.9 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.3 | 0.9 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.3 | 68.3 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.3 | 2.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.3 | 1.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.3 | 1.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.3 | 2.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.3 | 1.0 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.3 | 9.9 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.2 | 2.0 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.2 | 2.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 0.7 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 4.9 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.2 | 2.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 3.6 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 0.4 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 5.7 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.2 | 1.7 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.2 | 0.2 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.2 | 2.5 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.2 | 1.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 2.0 | PID BMP PATHWAY | BMP receptor signaling |
0.2 | 4.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 1.7 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 0.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 0.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 2.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 1.2 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 0.5 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 0.7 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 3.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 1.6 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 1.6 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 0.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 1.1 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 0.3 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 0.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.5 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 0.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 0.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 0.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 1.6 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 0.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.7 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.7 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.9 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.2 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.0 | PID IL2 1PATHWAY | IL2-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 46.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
1.9 | 24.5 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
1.9 | 16.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
1.6 | 1.6 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
1.4 | 1.4 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
1.3 | 10.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.3 | 16.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
1.2 | 14.4 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
1.1 | 25.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
1.1 | 9.6 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
1.0 | 15.4 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
1.0 | 39.0 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
1.0 | 8.6 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.9 | 10.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.9 | 20.0 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.9 | 11.8 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.9 | 7.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.9 | 13.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.8 | 8.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.8 | 6.7 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.8 | 7.9 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.8 | 42.1 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.8 | 6.3 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.7 | 49.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.7 | 5.4 | REACTOME OPSINS | Genes involved in Opsins |
0.7 | 8.0 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.6 | 1.9 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.6 | 5.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.6 | 12.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.6 | 1.2 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.6 | 4.2 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.6 | 6.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.6 | 5.5 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.5 | 1.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.5 | 5.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.5 | 8.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.5 | 3.6 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.5 | 8.4 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.5 | 2.4 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.5 | 17.9 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.5 | 3.4 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.5 | 5.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.5 | 1.0 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.5 | 4.8 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.5 | 0.5 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.5 | 5.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.5 | 7.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.5 | 5.5 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.4 | 3.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.4 | 5.4 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.4 | 3.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.4 | 22.1 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.4 | 1.7 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.4 | 5.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.4 | 2.9 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.4 | 4.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.4 | 6.6 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.4 | 5.7 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.4 | 1.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.4 | 3.8 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.4 | 6.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.4 | 5.1 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.4 | 2.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.4 | 4.7 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.4 | 3.6 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.4 | 8.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.4 | 4.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.3 | 3.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 3.7 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.3 | 7.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 42.1 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.3 | 5.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.3 | 0.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.3 | 9.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.3 | 3.6 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.3 | 8.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.3 | 11.5 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.3 | 0.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.3 | 4.1 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.3 | 1.2 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.3 | 2.0 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.3 | 1.9 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.3 | 1.6 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.3 | 0.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.3 | 4.6 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.3 | 0.8 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.3 | 1.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.3 | 4.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.3 | 9.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.3 | 4.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 0.7 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 4.4 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.2 | 2.6 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.2 | 0.9 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.2 | 14.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.2 | 1.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.2 | 0.9 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.2 | 0.4 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.2 | 2.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 1.9 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 4.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 5.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.2 | 0.8 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 1.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.2 | 7.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 0.8 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.2 | 3.9 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.2 | 1.7 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 0.7 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 7.3 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.2 | 4.4 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.2 | 0.3 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 3.0 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.2 | 0.6 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 0.1 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.1 | 0.4 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 0.7 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 5.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 0.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 4.6 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 0.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.4 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 1.8 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 0.3 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.1 | 1.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 2.6 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 0.8 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 2.1 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 0.3 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 2.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.4 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 1.3 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 1.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 2.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 2.1 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 0.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 0.5 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 0.8 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 1.0 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 0.6 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.1 | REACTOME GABA RECEPTOR ACTIVATION | Genes involved in GABA receptor activation |
0.1 | 0.5 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 0.1 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 0.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 0.2 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 0.6 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 0.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 3.1 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 0.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.0 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.0 | 0.0 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 1.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.4 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.9 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 2.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 1.7 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.3 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 0.2 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.0 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.0 | 0.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.0 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.0 | 0.4 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.1 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.0 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.1 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |